-transparent.png){kind=logo}
The IL-4R exists in two forms, either membrane bound or as a soluble (s) molecule. Since the sIL-4R binds to its ligand with high affinity, thereby acting as an immunoregulatory molecule, we were interested in the processes leading to its release. First, the release of sIL-4R in the model of murine leishmaniosis was analyzed. Infection of mice with Leishmania major resulted in up-regulation of sIL-4R production by Ag-stimulated CD4+ T cells, with a maximum around 7 days after infection. To clarify the mechanisms underlying sIL-4R release, in vitro studies were performed. After stimulation of naive lymphoid cells with IL-4, sIL-4R release was dependent on up-regulation of spliced IL-4R mRNA, as shown by inhibition with specific antisense oligonucleotides. In contrast to this, no increase in the spliced IL-4R mRNA and no inhibitory influence of antisense oligonucleotides were observed after stimulation of T cells from IL-4-deficient mice with anti-CD3 mAb. Thus, TCR stimulation can lead to IL-4-independent sIL-4R production. Under these conditions proteolytic shedding of membrane-bound IL-4R appears to be the principal mechanism of release, since in contrast to stimulation with IL-4, iodinated sIL-4R could only be immunoprecipitated after cell surface labeling and subsequent TCR stimulation. The common gamma-chain, a component of the IL-4R complex, did not appear to be involved in the pathways leading to sIL-4R expression. This analysis suggests the existence of two differentially regulated pathways of sIL-4R release, possibly having different consequences for the regulation of IL-4 bioactivity.
H Blum, and
M Wolf, and
K Enssle, and
M Röllinghoff, and
A Gessner
March 1993,
Cytokine,
H Blum, and
M Wolf, and
K Enssle, and
M Röllinghoff, and
A Gessner
June 1994,
The Journal of infectious diseases,
H Blum, and
M Wolf, and
K Enssle, and
M Röllinghoff, and
A Gessner
March 1995,
European journal of immunology,
H Blum, and
M Wolf, and
K Enssle, and
M Röllinghoff, and
A Gessner
October 1994,
Infection and immunity,
H Blum, and
M Wolf, and
K Enssle, and
M Röllinghoff, and
A Gessner
December 1996,
Biochemical and biophysical research communications,
H Blum, and
M Wolf, and
K Enssle, and
M Röllinghoff, and
A Gessner
October 1995,
International archives of allergy and immunology,
H Blum, and
M Wolf, and
K Enssle, and
M Röllinghoff, and
A Gessner
October 1996,
The Journal of pharmacology and experimental therapeutics,
H Blum, and
M Wolf, and
K Enssle, and
M Röllinghoff, and
A Gessner
February 2003,
Medical microbiology and immunology,
H Blum, and
M Wolf, and
K Enssle, and
M Röllinghoff, and
A Gessner
May 2017,
Research in microbiology,
H Blum, and
M Wolf, and
K Enssle, and
M Röllinghoff, and
A Gessner
March 1997,
Cytokine,
